Sort
16,179 grants matching “malaria”
Malaria melatonin receptor signaling as a novel drug target
$431,485Andrew P Thomas · Rbhs-New Jersey Medical School · R01 · FY2016 · AI
Malaria melatonin receptor signaling as a novel drug target
$431,485Andrew P Thomas · Rbhs-New Jersey Medical School · R01 · FY2015 · AI
Malaria melatonin receptor signaling as a novel drug target
$431,485Andrew P Thomas · Rbhs-New Jersey Medical School · R01 · FY2014 · AI
Research Training in Infectious Diseases
$431,304Roy M Gulick · Weill Medical Coll Of Cornell Univ · T32 · FY2024 · AI
Resource for Nonhuman Primate Immune Reagents
$431,279Francois J Villinger · University Of Louisiana At Lafayette · R24 · FY2023 · OD
Validation of the ubiquinone synthesis pathway of Toxoplasma gondii as a novel drug target
$431,149Silvia N Moreno · University Of Georgia · R01 · FY2024 · AI
Validation of the ubiquinone synthesis pathway of Toxoplasma gondii as a novel drug target
$431,149Silvia N Moreno · University Of Georgia · R01 · FY2023 · AI
In vitro culture of Babesia microti
$431,143Sam R. Telford · Tufts University Boston · R61 · FY2025 · AI
Malaria Topoisomerase inhibitors
$431,121Pradipsinh K. Rathod · University Of Washington · R01 · FY2017 · AI
Malaria Topoisomerase inhibitors
$431,121Pradipsinh K. Rathod · University Of Washington · R01 · FY2016 · AI
NKT cells: Novel Protective T cells against malaria
$430,992New York University School Of Medicine · R21 · FY2001 · AI
Malaria Pathogenesis in South Asia
$430,913Pradipsinh K. Rathod · University Of Washington · U19 · FY2015 · AI
Eliminating trachoma with repeat mass drug treatment
$430,885Thomas M Lietman · University Of California, San Francisco · U10 · FY2007 · EY
MalariSense: Transdermal Bloodless and Reagent-Free Malaria Diagnostics
$430,682Dmitri Lapotko · Masimo Corporation · R01 · FY2016 · AI
Functional Genomics of Inversion 2La in Anopheles gambiae
$430,622Nora J Besansky · University Of Notre Dame · R01 · FY2013 · AI
Inhibitors of Purine Import into Plasmodium falciparum Kill Malaria Parasites
$430,604Myles H Akabas · Albert Einstein College Of Medicine · R01 · FY2015 · AI
Variant surface antigens in cerebral malaria pathogenesis
$430,243Christopher V. Plowe · University Of Maryland Baltimore · R01 · FY2016 · HL
Mapping Drug Resistance Genes in Plasmodium Falciparum
$430,219Tim J Anderson · Texas Biomedical Research Institute · R01 · FY2007 · AI
Anthropod vector-based vaccines for leishmaniasis
$430,185Richard G Titus · Colorado State University · R01 · FY2006 · AI
Pore Formation by Cholesterol Dependent Cytolysins
$430,136Rodney K. Tweten · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2011 · AI
B. thuringiensis Crystal Proteins as Powerful Next-Generation Anthelmintics
$430,096Raffi V Aroian · Univ Of Massachusetts Med Sch Worcester · R01 · FY2014 · AI
Evolutionary medicine in the development of antimalaria drugs
$430,049Daniel L. Hartl · Harvard University · R01 · FY2017 · AI
SCH: INT: Collaborative Research: Smart Intervention Strategies for Hepatitis C Elimination
$430,007Turgay Ayer · Georgia Tech Research Corporation · · FY2017 · CSE
Research Activities in Support of Malaria Prevention and Control in Uganda (PMI)
$430,000Matthew G Dorsey · University Of California, San Francisco · U01 · FY2015 · GH
Arthropod vector-based vaccines for leishmaniasis
$429,970Richard G Titus · Colorado State University · R01 · FY2008 · AI